Journal article

Looking deep into the heterogeneity of human epidermal growth factor receptor 2-positive breast cancer: Can we understand it better?

S Loi, P Savas

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2016

DOI: 10.1200/JCO.2015.64.7495

University of Melbourne Researchers

Grants

Citation metrics

5Scopus
4Web of Science
6Dimensions

Keywords

Benefit
2.1 Biological and Endogenous Factors
Pik3ca Mutations
Open-Label
Phase-3 Trial
Lapatinib
Breast Cancer
Rates
Therapy
3211 Oncology and Carcinogenesis
Multicenter
Women'S Health
Cancer
Trastuzumab
Science & Technology
32 Biomedical and Clinical Sciences
Genes
Oncology
Life Sciences & Biomedicine